How I built a $275 million biotech company from nothing

How I built a $275 million biotech company from nothing

The Journey of a Woman in Biotech: Overcoming Challenges

Introduction to the Founder

  • The speaker, Serbi Serna, shares her unique background as a woman of color without advanced degrees, feeling inadequate while starting her biotech company.
  • Despite numerous opportunities to quit, she persevered and founded a healthcare company that was later sold for $275 million.

Personal Health Crisis

  • Serna recounts her experience with ovarian cysts during high school, which led to significant health challenges and hospital visits.
  • Initial misdiagnosis almost resulted in unnecessary surgery; it took time to determine the nature of her condition.
  • She highlights the limitations of medical tests available at the time for diagnosing ovarian cysts and cancer.

Decision-Making Under Uncertainty

  • Faced with invasive surgery options that could affect fertility, Serna's family chose to wait and monitor her condition based on statistical probabilities.
  • After months of uncertainty, they were relieved when the cysts turned out not to be cancerous.

Inspiration for Change

  • This personal health scare ignited Serna's passion for women's health; she expressed a desire in her high school statement to start a company focused on this area.
  • Her journey led to founding Envision Medical after gaining engineering experience at Abbott Vascular and another startup.

Entrepreneurial Leap

  • At 24 years old, driven by her past experiences, she decided to create an early detection mechanism for ovarian cancer despite initial job satisfaction.
  • Early prototypes were developed using flexible metal materials aimed at addressing women's health issues.

Networking Challenges

  • Recognizing the importance of customer feedback, she sought advice from gynecologists but initially lacked connections in the field.
  • By creatively reaching out under false pretenses (pretending illness), she secured meetings with professionals who helped expand her network.

Fundraising Struggles

  • Securing seed funding proved difficult; Serna faced over 50 rejections from investors questioning both market viability and her qualifications as a founder.
  • She encountered dismissive attitudes towards women's health investments, highlighting systemic biases within venture capital.

Challenges and Triumphs in Women's Health Entrepreneurship

Overcoming Bias and Building a Supportive Network

  • The speaker emphasizes the importance of ignoring biases encountered as a woman in entrepreneurship, suggesting that there are supportive individuals who believe in one's potential.
  • She highlights her successful fundraising journey, raising $20 million in venture capital to advance her medical device through various stages, including clinical studies and FDA clearance.

Innovation in Medical Technology

  • The device developed is the first to collect cells from the fallopian tube for evaluation of malignant features, aiming to provide timely answers regarding cancerous conditions.
  • Despite initial intentions to build the company independently, an acquisition offer from Boston Scientific for $275 million presented a significant validation of her work.

Emotional Milestones and Validation

  • The moment of receiving the acquisition offer was filled with disbelief after years of struggle; it represented validation from an industry leader.
  • Signing the acquisition agreement while surrounded by family marked a pivotal emotional moment, symbolizing security for the product's future and its impact on women's health.

Transitioning to Mentorship and Leadership

  • Post-acquisition, she connected with Jared Friedman at Y Combinator (YC), leading to opportunities to share her story with aspiring founders.
  • Engaging with other founders allowed her experiences—struggles and failures—to be transformed into valuable lessons for others navigating similar paths.

Criteria for Supporting Founders

  • She encourages applicants to YC who are addressing real needs, emphasizing that expertise (MD or PhD credentials) is less important than understanding significant problems needing solutions.
Playlists: Backstory
Video description

In our new documentary series Backstory we’re profiling the extraordinary Group Partners at the heart of YC. And we’re kicking it off with Surbhi Sarna, YC’s first healthcare and biotech focused Group Partner. In 2018 Surbhi Sarna sold her company nVision for $275 million to one of the world’s leading healthcare companies. But to understand how Surbhi got where she is today, you have to go back to her sophomore year in high school, when a cancer scare upended her life and set her on an entirely new path. In this episode Surbhi opens up about her health scare, how it impacted her life going forward and how she was able to ignore the people who doubted her along the way. If you've ever felt undervalued or under appreciated, Surbhi's story will provide you with insights and advice on how to overcome those hurdles on your journey to starting a company. Apply to Y Combinator: https://yc.link/Backstory-apply Work at a Startup: https://yc.link/Backstory-jobs Chapters (Powered by https://bit.ly/chapterme-yc) - 00:00 - Backstory 01:00 - Problem with Ovarian Cyst 02:39 - How nVision Medical was Born? 03:34 - Working as an Engineer and Starting a Company 04:24 - Validating the Idea 05:52 - Fundraising to Build a Prototype 06:14 - Investors Reaction to Women's Health 06:45 - Difficulty as a Female Founder 07:22 - Getting Funded 08:13 - Acquisition by Boston Scientific 09:51 - First YC Healthcare and Bio Partner 11:10 - Outro: Being a Group Partner at YC Archival school footage provided courtesy of Ryan Briggs